Dabigatran malabsorption in amiodarone-induced thyrotoxicosis: a clinical report

被引:0
作者
Francesco Sbrana
Dario Genovesi
Giosuè Angelo Catapano
Luca Panchetti
Antonio Bottoni
Giorgio Iervasi
机构
[1] Fondazione Toscana Gabriele Monasterio,Institute of Clinical Physiology
[2] Italian National Research Council,undefined
来源
Internal and Emergency Medicine | 2016年 / 11卷
关键词
Atrial Fibrillation; Celiac Disease; Amiodarone; Enoxaparin; Dabigatran;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:889 / 890
页数:1
相关论文
共 35 条
  • [1] Ruff CT(2014)Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Lancet 383 955-962
  • [2] Giugliano RP(2001)The effects of amiodarone on the thyroid Endocr Rev 22 240-254
  • [3] Braunwald E(2011)Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists Thyroid 21 593-646
  • [4] Hoffman EB(2008)Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate Clin Pharmacokinet 47 285-295
  • [5] Deenadayalu N(2014)Insufficient anticoagulation with dabigatran in a patient with short bowel syndrome Thromb Haemost 112 419-420
  • [6] Ezekowitz MD(undefined)undefined undefined undefined undefined-undefined
  • [7] Camm AJ(undefined)undefined undefined undefined undefined-undefined
  • [8] Weitz JI(undefined)undefined undefined undefined undefined-undefined
  • [9] Lewis BS(undefined)undefined undefined undefined undefined-undefined
  • [10] Parkhomenko A(undefined)undefined undefined undefined undefined-undefined